Online Study of Individuals With Genetic Changes and Features of Autism: Simons Variation in Individuals Project (Simons VIP)



Status:Recruiting
Conditions:Other Indications, Psychiatric
Therapuetic Areas:Psychiatry / Psychology, Other
Healthy:No
Age Range:Any
Updated:12/23/2017
Start Date:October 2010
End Date:July 2018
Contact:Simons VIP Study Coordinator
Email:coordinator@simonsvipconnect.org
Phone:855-329-5638

Use our guide to learn which trials are right for you!

Online Study of Individuals With Genetic Changes and Features of Autism: Simons Variation in Individuals Project (Simons VIP Phase 2)

The Simons Variation in Individuals Project (VIP) is characterizing the medical, behavioral,
and learning features of individuals with specific documented genetic changes associated with
features of autism and developmental delay with the goal of improving clinical care and
treatment for these individuals.

In Phase 2 (currently enrolling), the study has expanded to include more families with
genetic changes by including additional genetic changes of interest and offering
participation through a remote (online, phone) format. This allows English-speaking families
from across the world to participate at times convenient to their schedule. Biospecimens will
be collected from participants and linked to clinical data in order to understand the
relationship between specific genetic changes and the brain's development.

In Phase 1 (now closed to enrollment), the project assembled a team of experts at seven
premier medical centers to collect detailed clinical information from families through
in-person visits. This information has helped clinicians and families understand the
relationship between specific genetic changes and the brain's development.

Information from the project will be stripped of any personal identifying information and
made available to qualified scientists around the world.

The Simons Foundation, a New York-based private foundation, is committed to finding
science-based solutions and working towards the development of targeted treatments to improve
the lives of individuals with genetic and developmental differences.

Inclusion Criteria:

- Inclusion criteria will be any individual of any age with a confirmed genetic
diagnosis (or has had positive genetic testing results) in any of the following genes
or genomic regions:

1. 16p11.2 deletion or duplication (del/dup) defined as equal to or larger and
including the 16p11.2 susceptibility region 2. 1q21.1 deletion or duplication
(del/dup) defined as equal to or larger and including the 1q21.1 susceptibility region
3. Pathogenic variant (mutation) in any of the genes specified above. This includes
deletions meeting the following criteria: (i) Deletion includes all or part of a
single gene listed above (ii) Deletion size is less than 2 MB (iii) Deletion includes
less than or equal to 5 genes (in addition to gene of interest) with no known disease
association

- Both biological parents are encouraged to participate. Participants must be able to
speak and read English fluently.

- Any individual with features of autism who has had genetic testing and a known genetic
diagnosis may be eligible to participate; contact the study team for more information.

Exclusion Criteria:

- Exclusion criteria will include individuals who do not have the CNVs or genetic variants
in the genes specified about, or individuals who do not speak and read English fluently.

Individuals who do not have a genetic variation in one of the above listed genes or regions
are still encouraged to join the online community and submit a laboratory report for
review. Our study may expand to include more genes if greater than five unrelated
individuals with the same genetic variation register at Simons VIP Connect.
We found this trial at
1
site
Danville, Pennsylvania 17822
Phone: 570-522-9430
?
mi
from
Danville, PA
Click here to add this to my saved trials